REGENERON PHARMACEUTICALS, INC.
Latest Filing: Apr 29, 2026 • 25 Total Filings
Total Assets
2026
$40.87B
Total Revenue
2026
$3.61B
Net Income
2026
$727.20M
Operating Cash Flow
2026
$1.08B
Company Information
Ticker SymbolREGN
CIK872589
SIC CodeN/A
Total Filings25
Financial Snapshot
Total Assets$40.87B
Total Liabilities$9.45B
Total EquityN/A
Latest FilingApr 29, 2026